Injectable Cement Market Research, 2031
The global injectable cement market size was valued at $1,321.7 million in 2021, and is projected to reach $2,297.0 million by 2031, growing at a CAGR of 5.7% from 2022 to 2031. Injectable cement is the biocompatible material placed into the spine to anchor prosthetic parts to bone for treating osteoporotic fractures and bone defects. The injectable cement has attracted increased attention, due to beneficial properties, such as osteoconductivity, biocompatibility, anti-washout ability, and hardening ability through a low-temperature setting reaction. Calcium phosphate biomaterials (CaP) are widely used as injectable cement in medical and dental applications. Furthermore, injectable cement is used in maxillofacial surgeries, bone fractures, and bone augmentation due to osteoporosis.
The growth of the global injectable cement market size is majorly driven by the increase in the number of orthopedic surgeries, rise in number of injectable cement industry and increase in use of injectable cement for osteoporosis and trauma injuries. Furthermore, rise in road accident cases and sport injuries is the key factor contributing toward the market growth. For instance, according to National Crime Records Bureau (NCRB), about 437,396 road accident cases were reported in 2019, in India. In addition, rise in the bone fracture incidences among the adult population augments the demand for injectable cement, thus propelling the growth of the market. For instance, according to National Library of Medicine, in 2019, total 688,403 fractures were registered in Germany.
In addition, increase in the prevalence of chronic orthopedic diseases such as osteoarthritis and osteoporosis, surge the demand for injectable cement, thus propelling the injectable cement market growth. Furthermore, rise in healthcare expenditure also provides lucrative opportunities for the growth of the market in developing countries, such as India and China.
However, high cost of surgical treatments and side-effects associated with injectable cement negatively impact the growth of the market. For instance, low mechanical strength of calcium phosphate cement limits their use in load bearing regions of bone. In addition, polymethylmethacrylate (PMMA) has poor biological performance, excessive stiffness, and short handling time.
Moreover, the global market expansion is being fueled by factors, such as rise demand of injectable cement in various orthopedic surgeries and rise in healthcare expenditure in developing countries, such as India and China.
During the COVID-19 pandemic, shutdown of various plants affected the global supply chain and negatively impacted the manufacturing and sales of injectable cement in the global market. Some companies have already announced possible delays for new injectable cement, thus restraining the market growth. Furthermore, the outbreak of COVID-19 impacted the market, as hospital and healthcare services were significantly reduced due to social distancing measures taken by governments to stop COVID-19 spread.
Injectble cement market segmentation
The injectable cement market share is segmented into type, application and end user, and region. By type, it is segmented into low viscosity cement, medium viscosity cement, and high viscosity cement. By application, it is divided into spine fusion, bone fracture, and others. By end user, it is segmented into hospital, clinics, and, others.
Region-wise, the market is studies across North America, Europe, Asia-Pacific, and LAMEA.
Injectable Cement Market By Type
By type, the high viscosity cement segment dominated the market in terms of revenue in 2021, due to increase in use of bone cement in bone fracture treatment and various advantages of high viscosity cement such as low setting time and better prosthetic fixation. For instance, Palacos-R is a high viscosity cement manufactured by Zimmer Biometm, which has faster dough time as compared to other low viscosity cement.
Injectable Cement Market By Application
By application, the bone fracture segment dominated the market in terms of revenue in 2021 and is expected to continue this trend during the injectable cement market forecast, due to rise in geriatric population and increase in prevalence of osteoporosis. This is attributed to the fact that, osteoporosis can cause bones to become so brittle, which ultimately leads to bone fracture.
Injectable Cement Market By End User
By end user, the hospital segment dominated the market in terms of revenue in 2021, and is expected to continue this trend during the forecast period, due to increase in number of hospitals. For instance, according to a survey conducted by American Hospital Association, in 2022, the total number of hospitals in the U.S. were 6,093.
Injectable Cement Market By Region
North America was dominant, in terms of revenue among other regions in 2021, due to high adoption of minimally invasive surgeries such as spine fusion and well-established healthcare infrastructure, availability of novel products, and strong presence of injectable cement industry in this region. On the other hand, Asia-Pacific is expected to witness a considerable growth from 2022 to 2031, due to high patient pool among China and India, increase in road accident traffic accident cases, and rise in research and development activities in the pharmaceutical sector.
Some of the major companies that operate in the global injectable cement market share include, Arthrex Inc., B. Braun Melsungen AG, Cook Medical, Enovis, Johnson and Johnson, Medacta International SA, Medtronic plc, Smith and Nephew, Stryker Corporation, and Teknimed.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the injectable cement market analysis from 2021 to 2031 to identify the prevailing injectable cement market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the injectable cement market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global injectable cement market trends, key players, market segments, application areas, and market growth strategies.
Injectable Cement Market Report Highlights
| Aspects | Details |
 Market Size By 2031 | USD 2.3 billion |
 Growth Rate | CAGR of 5.7% |
 Forecast period | 2021 - 2031 |
 Report Pages | 226 |
 By Type |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Medtronic plc, Medacta International SA, Arthrex, B. Braun Melsungen AG, Stryker Corporation, cook medical, Enovis (DJO Global, Inc.), Teknimed, smith and nephew, johnson and johnson md&d |
Analyst Review
According to the insights of the CXOs, the global injectable cement market is expected to exhibit high growth potential attributable to factors, such as increase in orthopedic surgeries, growing old age population, rise in R&D activities in pharmaceutical industry for manufacturing injectable cement, and surge in number of approvals by the U.S. Food and Drug Administration (FDA) for injectable cement.
The CXOs further added that North America is expected to witness the highest growth, in terms of revenue, owing to increase in demand for injectable cement in orthopedic surgeries and strong presence of key players. However, Asia-Pacific is expected to register fastest CAGR during the forecast period due to rise sport injuries and increase in healthcare expenditure
The top companies that hold the market share in injectable cement market are Arthrex Inc., B. Braun Melsungen AG, Cook Medical, Enovis, Johnson and Johnson, Medacta International SA, Medtronic plc, Smith and Nephew, Stryker Corporation, and Teknimed
Asia-Pacific is expected to register highest CAGR from 2022 to 2031, owing to high patient pool among China and India, increase in road accident traffic accident cases, and rise in research and development activities in the pharmaceutical sector.
The key trends in the injectable cement market are increase in number of orthopedic surgeries and increase in use of injectable cement for osteoporosis and trauma injuries.
The base year for the report is 2021.
Yes, injectable cement companies are profiled in the report
The total market value of injectable cement market is $1,321.7 million in 2021.
The forecast period in the report is from 2022 to 2031
The market value of injectable cement market in 2022 was $1,394.4 million
Loading Table Of Content...
